VANCOUVER, BRITISH COLUMBIA, CANADA, August 7, 2025 /EINPresswire.com/ — In response to a growing public interest in science-based solutions for aging, confidence, and long-term wellbeing, Vivacity: The Medical Aesthetics, Longevity & Healthy Aging Show is set to launch at the Vancouver Convention Centre West from September 19–21, 2025.
The three-day event arrives at a moment when individuals are increasingly seeking credible information about how to maintain their health, enhance their appearance, and feel empowered in their wellness journeys. With more people turning to preventative health, hormone therapy, functional medicine, and medical aesthetics, Vivacity aims to create a public forum where these topics can be explored openly and responsibly.
“Vivacity is about access—access to credible education, experienced professionals, and up-to-date information based in science,” said Jason Heard, Show Director. “We want to help close the gap between medical knowledge and public understanding by offering a space where real conversations can happen.”
The show will span over 50,000 square feet, featuring:
-Exhibitor booths from leading organizations in medical aesthetics, regenerative medicine, hormone health, sexual wellness, and more
-Live demonstrations and treatments designed to help attendees better understand procedures and outcomes
-A judgment-free, science-driven environment that encourages curiosity and dialogue on topics often overlooked or rushed in traditional healthcare settings
A key feature of the show is its comprehensive speaker program, to be officially announced on August 15. The lineup will include more than 35 presentations across two stages, covering subjects such as anti-aging science, cosmetic procedures, hormone optimization, skin health, mental wellbeing, and sexual health. The sessions are tailored to deliver practical, evidence-based insights for anyone seeking to better navigate their own health and wellness decisions.
Vivacity also reflects a cultural shift toward proactive self-care, where individuals increasingly seek personalized, preventative solutions rather than one-size-fits-all treatments.
Whether you’re exploring new approaches to skin health, curious about the role of hormones in aging, or want to better understand longevity science, Vivacity offers a space to ask questions, gain clarity, and engage directly with experts.
For inquiries:
Jason Heard
Director, Vivacity
Email: jason@VivacityShow.com
Phone: 604.220.2725
About PanGenomic Health
PanGenomic Health is a precision health company that has developed a self-care digital platform
to deliver personalized, evidence-based information about natural treatments. The Company’s
initial focus is to support mental health. Registered as a British Columbia benefit company,
PanGenomic Health’s mission is to promote and improve the health and wellness of people and
society by providing a technology platform that identifies plant-based solutions tailored to the
health profile of each individual.
For more information, please contact:
Jerry Lai, Investor Relations
PanGenomic Health Inc.
+1 778 743 4642
ir@pangenomic.com
This news release includes certain statements that may be deemed “forward-looking statements”,
including statements respecting the services to be provided by PanGenomic Health and the
consideration to be paid to PanGenomic Health. The use of any of the words “anticipate”,
“continue”, “estimate”, “expect”, “may”, “will”, “would”, “project”, “should”, “believe” and similar
expressions are intended to identify forward looking statements. Although PanGenomic Health
believes that the expectations and assumptions on which the forward-looking statements are
based are reasonable, undue reliance should not be placed on the forward-looking statements
because PanGenomic Health can give no assurance that they will prove to be correct. Since
forward-looking statements address future events and conditions, by their very nature they involve
inherent risks and uncertainties. These statements speak only as of the date of this News
Release. Actual results could differ materially from those currently anticipated due to a number of
factors and risks including various risk factors discussed in PanGenomic Health’s disclosure
documents which can be found under PanGenomic Health’s profile on www.sedarplus.ca.
The Canadian Securities Exchange has neither approved nor disapproved the information
contained herein and does not accept responsibility for the adequacy or accuracy of this
news release.
